Skip to content

Clinical trials

Phase 4 Carcinoma, Non-Small-Cell Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 4 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20091
20141
20151
20161
20181
20192
20201
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Boehringer Ingelheim2
Novartis Pharmaceuticals2
Celgene1
Fox Chase Cancer Center1
Genentech, Inc.1
Lisa Sanderson Cox, PhD1
Michael Mann1
OHSU Knight Cancer Institute1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms7
Carcinoma, Hepatocellular3
Carcinoma, Renal Cell3
Small Cell Lung Carcinoma3
Esophageal Neoplasms2
Head and Neck Neoplasms2
Hypopharyngeal Neoplasms2
Kidney Neoplasms2
Laryngeal Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.